Study Suggests Pegylated Interferon Alpha Offers Best Treatment Option for Chronic Hepatitis B Infection

Article

Results of an international study in this weeks issue of The Lancet suggest that pegylated interferon alpha offers the best treatment option for people with chronic hepatitis B infection.

 

Patients successfully treated for chronic hepatitis B are less likely to develop cirrhosis, liver failure, and liver cancer. Previous research has suggested that treatmenteither with standard interferon a or nucleoside analoguesis only around 20 percent effective at best.

 

Harry Janssen of the Erasmus University Medical Centre in Rotterdam, Netherlands, and colleagues assessed whether combination treatment with pegylated interferon alpha-2 beta and the antiviral agent lamivudine was more efficacious in treating chronic hepatitis B infection than pegylated interferon alpha-2 beta therapy alone. Around 300 patients from 42 centers in 15 countries who had chronic hepatitis B were assigned combination therapy or monotherapy for one year.

 

Thirty-six percent of patients assigned monotherapy and 35 percent assigned combination therapy had a sustained viral response (clearance of the hepatitis B e Ag) indicating disease remission at the end of the half year follow-up period.

 

The study also highlights the importance of hepatitis B virus genotype as a predictor of response to pegylated interferon.

 

Source: The Lancet

 

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content